Current stock page

Stock Analysis

CONMED Corporation (CNMD) Stock Analysis

CONMED Corporation (CNMD) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

CNMD Stock Analysis Summary

CONMED Corporation (CNMD) currently has an AIQ Score of 71/100, indicating a bullish setup. Value is the strongest factor at 84/100. Risk is the weakest current factor at 58/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 18, 2026 · Market-close data

CNMD at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$48.01
AIQ Score71/100
Overall ViewBullish
Technical Analysis ConsensusStrong Buy
Market Cap$1.51B
P/E Ratio (TTM)20
Forward P/E—
EPS (Q3 FY2026)$0.66
Revenue (Q3 FY2026)$335.56M
Dividend Yield (TTM)0.00%
Beta0.79
Volume359.69K
52-week range$31.44-$54.80
RSI 1456.85
50-Day SMA$47.17
200-Day SMA$41.91
Analyst Price Target$50.00
Next EarningsJan 27, 2027
As of Nov 18, 2026 · Market close

CNMDCONMED Corporation

Healthcare / Medical - Devices

Leader

Strong Relative Position

BullishEdge 9/10
$48.01−$0.38 (−0.79%)

Latest quote

  • Momentum
    74
  • Value
    84
  • Quality
    66
  • Risk resilience
    58
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

CNMD Stock Analysis Summary

CONMED Corporation (CNMD) currently has an AIQ Score of 71/100, indicating a bullish setup. Value is the strongest factor at 84/100. Risk resilience is the weakest current factor at 58/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 18, 2026 · Market-close data
AIQ Composite Posture: Bullish

In a bullish regime, CNMD has AIQ Score of 71/100 with Value base of 84/100 and fading Risk resilience at 58/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Value (84/100) leads while Risk resilience (58/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · -0.79% stock move · CNMD classified in Medical - Devices.

Current Evidence

BullishCNMD is in a bullish AIQ regime; Value is the strongest visible factor at 84/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is CNMD Bullish or Bearish Right Now?

CNMD currently has a bullish overall setup. Value is the strongest factor at 84/100, while Risk Resilience is weakest at 58/100. The current evidence suggests a constructive setup.

Bull Case
  • - Quality is supportive at 66/100.
  • - Momentum is constructive at 74/100.
  • - Price is +7.26% above its 50-day SMA.
  • - Analyst target implies +4.14% upside from the latest quote.
  • - Technical consensus has more buy votes than sell votes (34 vs 3).
Bear Case
  • - No strong bearish evidence is available in the current snapshot.

Current Consensus

CNMD's Technical Analysis Consensus is currently Strong Buy, with 34 buy, 9 neutral, and 3 sell votes. CNMD's 14-day RSI is 56.85, which places the stock in a constructive momentum range. CNMD's beta is 0.79, indicating lower market sensitivity than the broad market.

Signal Confidence
High agreement

What Changed in CNMD?

The largest recent change in CNMD is Momentum moving down by 6.0 points over the available 7-day comparison window. Value remains the strongest visible factor.

AIQ Score
-2.0
Momentum
-6.0
Quality
+1.0
Risk
+0.0

What Would Change the CNMD Outlook?

The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

CNMD Decision Framework

Public evidence layers, setup checks, and risk context for CONMED Corporation.

CONMED Corporation (CNMD) Stock Analysis

CONMED Corporation has an AIQ Score of 71/100 in a Bullish regime. Value is strongest at 84/100. Beta is 0.79, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextCNMD is in a Bullish AIQ regime with score 71/100.
Signal ConflictThe primary conflict is that value leads at 84/100 while risk lags at 58/100.
Factor EvidenceMomentum 74/100 · Value 84/100 · Quality 66/100 · Risk 58/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Value is the strongest factor at 84/100.

TimingPass

Momentum is 74/100 and RSI (14) is 56.8.

Regime fitPass

CNMD is in a Bullish regime at 71/100.

Risk controlWait

Risk factor is 58/100 with beta 0.79 and annual volatility 46.99%.

ConflictWait

Current conflict: value leads at 84/100 while risk lags at 58/100.

AIQ Score
71/100
Price
$48.01
Beta
0.79
RSI (14)
56.8

CNMD Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

CNMD Fundamentals

CNMD valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$335.56M
Net income
$19.8M
Free cash flow
$46.73M
View full CNMD fundamental analysis

CNMD Technical Analysis

CNMD technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Buy
RSI 14
56.85
Price vs SMA-50
+7.26%
View full CNMD technical analysis

CNMD Stock Catalysts

Track CNMD earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Jan 27, 2027
Analyst target
$50.00
News items
1
View CNMD earnings and stock catalysts

CNMD Dividend Analysis

CNMD dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
1.67%
Annual dividend
$0.80
Payout ratio
—
View CNMD dividend history and analysis

CNMD Financial Data

CNMD revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$335.56M
EPS
$0.66
Periods
8
View CNMD financials

CNMD Risk Analysis

CNMD volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
0.79
Risk score
58/100
1Y volatility
46.99%
View CNMD risk analysis

CNMD Stock News

CNMD stock news, market tone, recent headlines, and catalyst context.

News items
1
Updated
Nov 18, 2026
Sentiment
—
Read CNMD stock news

CNMD vs Medical - Devices Peers

Current peer cohort: CNMD · ESTA · GKOS · HAE · IRTC. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
CNMD
Current stock
————0.4846.99%Current
ESTA
Establishment Labs Holdings Inc.
————0.3549.89%CNMD vs ESTA
GKOS
Glaukos Corporation
————1.8361.36%CNMD vs GKOS
HAE
Haemonetics Corporation
————1.3541.04%CNMD vs HAE
IRTC
iRhythm Technologies, Inc.
————-0.9154.02%CNMD vs IRTC
Pairwise Compare links: ESTA · GKOS · HAE · IRTCCNMD vs ESTACNMD vs GKOSCNMD vs HAECNMD vs IRTCCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 18, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 18, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a CNMD stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for CNMD: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 19, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
20
As of Nov 18, 2026
Revenue growth
-0.89%
Gross margin
57.20%
Current debt / equity
0.77
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$335.56M
Quarter net income
$19.8M
Quarter free cash flow
$46.73M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bullish
Momentum
Bullish
RSI 14
56.85
MACD
1.23

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
58/100
Beta
0.79
Annual volatility
46.99%
Max drawdown
-30.29%

CNMD Stock FAQ

What is CNMD stock price today?

CONMED Corporation's current stock price is $48.01. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is CNMD bullish or bearish right now?

CNMD's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is CNMD's market cap?

CNMD's market cap is $1.51B based on the latest completed market-close snapshot from Nov 18, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is CNMD's current P/E ratio?

CNMD's current P/E ratio is 20 based on the latest completed market-close snapshot from Nov 18, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is CNMD's RSI?

CNMD's 14-day RSI is 56.85 based on the latest completed market-close snapshot from Nov 18, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is CNMD above its 50-day and 200-day moving averages?

CNMD is 7.26% from its 50-day SMA and 20.72% from its 200-day SMA based on the latest completed market-close snapshot from Nov 18, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is CNMD's next earnings date?

CNMD's next earnings date is currently listed as Jan 27, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does CNMD pay a dividend?

CNMD's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 18, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.